Is CK8 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CK8 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CK8 (€0) is trading below our estimate of fair value (€0.01)
Significantly Below Fair Value: CK8 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CK8?
Key metric: As CK8 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for CK8. This is calculated by dividing CK8's market cap by their current
revenue.
What is CK8's PS Ratio?
PS Ratio
4.6x
Sales
Rp15.94t
Market Cap
Rp72.77t
CK8 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: CK8 is expensive based on its Price-To-Sales Ratio (4.6x) compared to the European Multiline Retail industry average (0.8x).
Price to Sales Ratio vs Fair Ratio
What is CK8's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
CK8 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
4.6x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CK8's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst CK8 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€0.0025
€0.0053
+111.2%
18.2%
€0.0089
€0.0041
n/a
28
Nov ’25
€0.0055
€0.0051
-7.1%
19.7%
€0.0088
€0.0032
n/a
29
Oct ’25
€0.0025
€0.0051
+102.5%
23.4%
€0.0089
€0.0033
n/a
29
Sep ’25
n/a
€0.0048
0%
23.3%
€0.0087
€0.0032
n/a
28
Aug ’25
€0.0025
€0.0049
+95.4%
23.9%
€0.0086
€0.0031
n/a
27
Jul ’25
€0.002
€0.0051
+157.0%
23.9%
€0.0085
€0.0037
n/a
26
Jun ’25
n/a
€0.0056
0%
29.3%
€0.011
€0.0037
n/a
28
May ’25
€0.005
€0.0056
+12.9%
29.3%
€0.011
€0.0037
n/a
28
Apr ’25
n/a
€0.0058
0%
28.4%
€0.011
€0.0038
n/a
28
Mar ’25
€0.0055
€0.006
+9.3%
27.7%
€0.011
€0.0035
n/a
28
Feb ’25
€0.0065
€0.0061
-6.1%
30.9%
€0.011
€0.0029
n/a
28
Jan ’25
€0.0035
€0.0064
+81.7%
35.1%
€0.011
€0.0029
n/a
28
Dec ’24
€0.0058
€0.0062
+7.4%
37.3%
€0.012
€0.003
n/a
29
Nov ’24
n/a
€0.0066
0%
36.8%
€0.012
€0.003
€0.0055
29
Oct ’24
n/a
€0.0078
0%
24.2%
€0.012
€0.0046
€0.0025
26
Sep ’24
n/a
€0.0078
0%
23.3%
€0.012
€0.0046
n/a
28
Aug ’24
n/a
€0.0084
0%
20.8%
€0.013
€0.0045
€0.0025
26
Jul ’24
n/a
€0.0086
0%
24.6%
€0.015
€0.0046
€0.002
24
Jun ’24
n/a
€0.0091
0%
24.9%
€0.015
€0.0046
n/a
22
May ’24
n/a
€0.0092
0%
25.3%
€0.016
€0.0047
€0.005
22
Apr ’24
n/a
€0.0095
0%
24.7%
€0.015
€0.0049
n/a
21
Mar ’24
n/a
€0.01
0%
32.4%
€0.02
€0.0049
€0.0055
20
Feb ’24
n/a
€0.011
0%
34.9%
€0.02
€0.0049
€0.0065
19
Jan ’24
n/a
€0.014
0%
37.2%
€0.026
€0.0048
€0.0035
19
Dec ’23
n/a
€0.017
0%
35.9%
€0.031
€0.0089
€0.0058
17
Nov ’23
n/a
€0.021
0%
28.3%
€0.033
€0.013
n/a
16
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.